Correspondence 0001493152-23-034574 from Syra Health Corp (SYRA) (CIK 0001922335) (SYRA)
Syra Health Corp (SYRA) (CIK 0001922335)
Date: Sept. 28, 2023 · CIK: 0001922335 · Accession: 0001493152-23-034574
AI Filing Summary & Sentiment
File numbers found in text: 333-271622
Letter
September 28, 2023
VIA EDGAR
United States Securities and Exchange Commission
F. Street, NE
Washington, DC 20549
Attn: Scott Stringer
Joel Parker
Brian Fetterolf
Erin Jaskot
Re: Syra Health Corp.
Registration Statement on Form S-1, as amended
File No. 333-271622
Ladies and Gentlemen:
As representative of the several underwriters of the proposed offering of Syra Health Corp. (the “Company”), we hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness at 4:30 p.m., Eastern Time, on Thursday, September 28, 2023, or as soon thereafter as possible.
The undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
Sincerely,
Kingswood, a division of Kingswood Capital Partners, LLC
Show Raw Text
CORRESP
1
filename1.htm
September
28, 2023
VIA
EDGAR
United
States Securities and Exchange Commission
100
F. Street, NE
Washington,
DC 20549
Attn:
Scott
Stringer
Joel
Parker
Brian
Fetterolf
Erin
Jaskot
Re:
Syra
Health Corp.
Registration
Statement on Form S-1, as amended
File
No. 333-271622
Ladies
and Gentlemen:
As
representative of the several underwriters of the proposed offering of Syra Health Corp. (the “Company”), we
hereby join the Company’s request for acceleration of the above-referenced Registration Statement, requesting effectiveness at
4:30 p.m., Eastern Time, on Thursday, September 28, 2023, or as soon thereafter as possible.
The
undersigned advise that they have complied and will continue to comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as
amended.
Sincerely,
Kingswood, a division of Kingswood Capital Partners, LLC
By:
/s/
Tyler Bashaw
Name:
Tyler
Bashaw
Title:
Director